Journal of the Neurological Sciences
Volume 229 , Pages 7-12 , 15 March 2005

Cerebral microangiopathy in the mosaic of new discoveries

References 

  1. Alzheimer A. Die arteriosklerotische atrophie des gehirns. Allg. Z. Psychiatr. Psych.-Gerichtl. Med. 1895;51:809–812
  2. Bowler J, Hachinski V. History of the concept of vascular dementia: two opposing views on current definitions and criteria for vascular dementia. In:  Prohovnik I,  Wade J,  Knezevic S,  Tatemichi T,  Erkinjuntti T editor. Vascular Dementia, Current Concepts. Chichester: John Wiley; 1996;p. 1–28
  3. Hachinski VC, Lassen NA. Multiinfarct dementia, a cause of mental deterioration in the elderly. Lancet. 1974;2:207–210
  4. O'Brien MD. Vascular dementia is underdiagnosed. Arch. Neurol. 1988;45:797–798
  5. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Graftstrom M, Holmen K, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relation with age, sex and education. Neurology. 1991;41:1886–1893
  6. Schoenberg BS, Anderson DW, Haerer AF. Severe dementia: prevalence and clinical features in a biracial US population. Arch. Neurol. 1985;42:740–742
  7. Yamaguchi T, Yoshida F. Epidemiology of vascular dementia in Japan. In:  Román GC,  Schoenberg DG editor. Vascular Dementia. New Issues in Neurosciences. Basic and Clinical Approaches. Stuttgart: Thieme; 1992;p. 100–102
  8. Ueda K, Kawano H, Hasuo Y, Fugishima M. Prevalence and etiology of dementia in a Japanese community. Stroke. 1992;23:798–803
  9. Li G, Shen YC, Chen CH, Zhao YW, Li SR, Lu M. An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr. Scand. 1989;79:557–563
  10. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 1987;76:465–479
  11. Katzman R, Lasker B, Bernstein N. Advances in the diagnosis of dementia: accuracy of diagnosis and consequences of misdiagnosis of disorders causing dementia. In:  Terry RD editors. Aging and the Brain. New York: Raven Press; 1988;p. 17–62
  12. Tatemichi TK, Desmond DW. Epidemiology of vascular dementia. In:  Prohovnik I,  Wade J,  Knezevic S,  Tatemichi T,  Erkinjuntti T editor. Vascular Dementia, Current Concepts. Chichester: John Wiley; 1996;p. 41–71
  13. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke. 1998;29:75–81
  14. Desmond DW, Moroney JT, Paik MC, Sano M, Mohr JP, Aboumatar S, et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology. 2000;54:1124–1131
  15. Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia: a clinical and brain imaging experience. Drug Res. 1995;45:371–385
  16. O'Brien MD. How does cerebrovascular disease cause dementia?. Dementia. 1994;5:133–136
  17. Dechambre A. Mémoire sur la curabilité du ramollisement du cerveau. Gaz. Méd. Paris. 1838;6:305–314
  18. Binswanger O. Zur Klinik und pathologischen Anatomie der arteriosklerotischen Hirnerkrankung. Dtsch. Med. Wochenschr. 1908;50:2199
  19. Román GC. On the history of lacunes, etat criblé, and the white matter lesions of vascular dementia. Cerebrovasc. Dis. 2002;13(Suppl. 2):1–6
  20. Bell MA, Ball MJ. Cerebral vessels in aging and Alzheimer's dementia: morphometric changes, tortuosity and relationship to neuritic plaques. In:  Román GC,  Schoenberg DG editor. Vascular Dementia. New Issues in Neurosciences. Basic and clinical approaches. Stuttgart: Thieme; 1992;p. 121–132
  21. Moody DM, Bell MA, Challa VR. Regional cerebral vulnerability to perfusion deficits in the elderly. In:  Román GC,  Schoenberg DG editor. Vascular Dementia. New Issues in Neurosciences. Basic and clinical approaches. Stuttgart: Thieme; 1992;p. 133–145
  22. Gregová D, Korsa J, Peisker T, Termerová J, Procházka B, Kalvach P. Age dependence of carotid blood flow velocity. In: Book of Abstracts. 3rd International Congress on Vascular Dementia, Prague, Czech Republic, October 23–26. 2003;
  23. Kalvach P, Schickerová R, Vymazal J. Nejčastèjší lokalizace mozkových ischemických iktů: III. Status lacunaris cerebri (in Czech). Čas. Lék. Čes. 1989;128:1224–1229
  24. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30:1174–1180
  25. Ay H, Oliveira-Filho J, Buonanno FS, Schaefer PW, Furie KL, Chang YC, et al. “Footprints” of transient ischemic attacks: a diffusion-weighted MRI study. Cerebrovasc. Dis. 2002;14:177–186
  26. Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Sheltens P, et al. CT and MRI rating of white matter lesions. Cerebrovasc. Dis. 2002;13(Suppl. 2):31–36
  27. Barkhof F, Scheltens Ph. Imaging of white matter lesions. Cerebrovasc. Dis. 2002;13(Suppl. 2):21–30
  28. Longstreth WT, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274–1282
  29. Desmond DW. Cognition and white matter lesions. Cerebrovasc. Dis. 2002;13(Suppl. 2):53–57
  30. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis. 2002;13(Suppl. 2):48–52
  31. Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, et al. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA. 2000 (Mar 22–29);283(12):1571–1577
  32. Greenberg SM, Vonsattel JPG. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke. 1997;28:1418–1422
  33. Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, et al. Perfusion magnetic resonance imaging maps in hyperacute stroke. Relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke. 2001;32:1581–1587
  34. Nabavi DG, Cenic A, Henderson S, Gelb AW, Lee TY. Perfusion mapping using computed tomography allows accurate prediction of cerebral infarction in experimental brain ischemia. Stroke. 2001;32:175–183
  35. Enblad P, Frykholm P, Valtysson J, Silander HC, Andersson J, Fasth KJ, et al. Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke. 2001;32:1574–1580
  36. Syková E, Mazel T, Šimonová Z. Diffusion constraints and neuron–glia interaction during aging. Exp. Gerontol. 1998;33:837–851
  37. Syková E. Glial diffusion barriers during aging and pathological states. In:  Lopez BC, Nieto-Sampedro  editor. Progress in Brain Research. vol. 132:Elsevier Science B.V.; 2001;p. 339–363
  38. Olah L, Wecker S, Hoehn M. Relation of apparent diffusion coefficient changes and metabolic disturbances after 1 hour of focal cerebral ischemia and at different reperfusion phases in rats. J. Cereb. Blood Flow Metab. 2001;4:430–439
  39. Oppenheim C, Grandin C, Samson Y, Smith A, Duprez T, Marsault C, et al. Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke?. Stroke. 2001;32:2486–2491
  40. Neumann-Haefelin T, Kastrup A, de Crespigny A, Yenari MA, Ringer T, Sun GH, et al. Serial MRI after transient focal cerebral ischemia in rats. Stroke. 2000;31:1965–1973
  41. Liu KF, Li F, Tatlisumak T, Garcia JH, Sotak CH, Fisher M, et al. Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia. Stroke. 2001;32:1897–1905
  42. Bisschops RHC, Kappelle LJ, Mali WPTM, van der Grond J. Hemodynamic and metabolic changes in transient ischemic attack patients. A magnetic resonance angiography and 1H-magnetic resonance spectroscopy study performed within 3 days of onset of a transient ischemic attack. Stroke. 2002;33:110–115
  43. Helenius J, Soinne L, Salonen O, Kaste M, Tatlisumak T. Leukoaraiosis, ischemic stroke, and normal white matter on diffusion-weighted MRI. Stroke. 2002;33:45–50
  44. Hu BR, Janelidze S, Ginsberg MD, Busto R, Perez-Pinzon M, Sick TJ, et al. Protein aggregation after focal brain ischemia and reperfusion. J. Cereb. Blood Flow Metab. 2001;21:865–875
  45. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E. Impact of white matter changes on clinical manifestation of Alzheimer's disease. A quantitative study. Stroke. 2000;31:2182–2188

PII: S0022-510X(04)00435-6

doi: 10.1016/j.jns.2004.11.013

Journal of the Neurological Sciences
Volume 229 , Pages 7-12 , 15 March 2005

Article Tools

* Image Usage & Resolution